Tag: <span>plasma B cells</span>

Home / plasma B cells
Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective
Post

Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective

American Journal of Pathology publishes efficacy results from Houston Methodist clinical trial HOUSTON METHODIST HOUSTON METHODIST PHYSICIAN SCIENTIST ERIC SALAZAR, MD, PHD, LOOKS ON AS HIS TEAM WORKS IN THE LAB ON CONVALESCENT PLASMA RESEARCH. view more CREDIT: HOUSTON METHODIST HOUSTON-(Aug. 12, 2020) – A preliminary analysis of an ongoing study of more than 300...

Drug prevents multiple sclerosis relapses in phase 3 trial
Post

Drug prevents multiple sclerosis relapses in phase 3 trial

by University of California, San Francisco A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common form of the illness, in which symptoms wax and wane. MS is an autoimmune disease in which...

Immunoprotein impairs Sars-Cov-2
Post

Immunoprotein impairs Sars-Cov-2

An endogenous protein prevents the virus from fusing with host cells RUHR-UNIVERSITY BOCHUM STEPHANIE PFÄNDER IS LOOKING FOR GENES THAT INHIBIT CORONA VIRUSES. view more CREDIT: RUB, MARQUARD A protein produced by the human immune system can strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the...

Immune response to COVID-19’s spike protein – the secret to a successful vaccine?
Post

Immune response to COVID-19’s spike protein – the secret to a successful vaccine?

by Doherty Institute for Infection and Immunity Scientists have uncovered how a crucial component of the immune system responds to the spike protein of SARS-CoV-2, the virus that causes COVID-19—important information for future validation of vaccine candidates. Coronavirus particles have a corona (crown) of proteins that resemble spikes, which enable the virus to attach and...

The protein that stands between us and autoimmunity
Post

The protein that stands between us and autoimmunity

by Osaka University Tet-mediated B cell tolerance Tet2/3-deficient B cells are activated by self-antigen and express exaggerated amount of CD86. Then those B cells stimulate autoreactive CD4+ T cells, resulting in autoimmune response. Credit: Osaka University The immune system is supposed to protect from external microbial invaders, but sometimes it turns its efforts inward, potentially...

B-cell protectors
Post

B-cell protectors

MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE IN THE HELMHOLTZ ASSOCIATION THE PROTEIN PDAP1 (RED) IS LOCATED IN THE CYTOPLASM OF B CELLS. view more CREDIT: DI VIRGILIO, MDC Whenever a germ gets into the human body, the immune system usually responds immediately to fight off the enemy attacker. One of our defense system’s most important...

A metabolic enzyme drives lymphoma and is a potential drug target
Post

A metabolic enzyme drives lymphoma and is a potential drug target

by Memorial Sloan Kettering Cancer Center Because of how aggressively they divide, cancer cells have an increased demand for building materials and energy. They meet these added demands by altering their metabolism—taking in larger amounts of fuel, for example. Historically, these metabolic changes have been considered a consequence rather than a cause of cancer, and...

  • 1
  • 2